We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+4.33%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.68B
AUM Growth
-$209M
Cap. Flow
-$341M
Cap. Flow %
-9.26%
Top 10 Hldgs %
13.58%
Holding
1,437
New
112
Increased
524
Reduced
590
Closed
111

Sector Composition

Rank Sector Weight
1 Technology 12.63%
2 Healthcare 11.47%
3 Financials 11.29%
4 Industrials 9.35%
5 Consumer Discretionary 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
26
Citigroup
C
$222B
$23.5M 0.64%
350,658
-18,963
-5% -$1.31M
EPD icon
27
Enterprise Products Partners
EPD
$82.5B
$23.3M 0.63%
841,804
-238,812
-22% -$6.53M
MTUM icon
28
iShares MSCI USA Momentum Factor ETF
MTUM
$24.9B
$23.1M 0.63%
210,670
+24,179
+13% +$2.65M
IBM icon
29
IBM
IBM
$209B
$22.8M 0.62%
170,846
-96
-0.1% -$13.4K
DIS icon
30
Walt Disney
DIS
$167B
$22.8M 0.62%
217,252
+1,966
+0.9% +$201K
SPY icon
31
State Street SPDR S&P 500 ETF Trust
SPY
$784B
$22.7M 0.62%
83,812
+464
+0.6% +$125K
VZ icon
32
Verizon
VZ
$193B
$22.3M 0.61%
443,797
+13,321
+3% +$645K
BA icon
33
Boeing
BA
$175B
$22.2M 0.6%
66,218
-1,302
-2% -$448K
INTC icon
34
Intel
INTC
$460B
$21M 0.57%
421,573
+12,624
+3% +$670K
NVGS icon
35
Navigator Holdings
NVGS
$1.37B
$21M 0.57%
1,656,693
+79,154
+5% +$902K
CVX icon
36
Chevron
CVX
$383B
$20M 0.54%
158,023
+9,639
+6% +$1.2M
LUV icon
37
Southwest Airlines
LUV
$22.3B
$19.6M 0.53%
384,471
+27,477
+8% +$1.45M
TMO icon
38
Thermo Fisher Scientific
TMO
$214B
$19.5M 0.53%
94,181
-282
-0.3% -$59.9K
NFLX icon
39
Netflix
NFLX
$305B
$19.1M 0.52%
487,690
+290
+0.1% +$9.89K
BMY icon
40
Bristol-Myers Squibb
BMY
$132B
$19M 0.51%
342,518
-2,437
-0.7% -$132K
ABBV icon
41
AbbVie
ABBV
$455B
$18.9M 0.51%
203,657
+3,114
+2% +$304K
HON icon
42
Honeywell
HON
$76.7B
$17.8M 0.48%
136,934
-32,884
-19% -$4.37M
PEP icon
43
PepsiCo
PEP
$191B
$17.6M 0.48%
162,029
+3,168
+2% +$327K
MRK icon
44
Merck
MRK
$321B
$17.3M 0.47%
298,409
+3,941
+1% +$222K
MDY icon
45
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$16.8M 0.46%
47,241
-516
-1% -$181K
RTN
46
DELISTED
Raytheon Company
RTN
$16.3M 0.44%
84,586
+4,511
+6% +$948K
BABA icon
47
Alibaba
BABA
$279B
$16M 0.43%
86,305
-25,849
-23% -$4.93M
EHC icon
48
Encompass Health
EHC
$11B
$15.8M 0.43%
293,075
-33,380
-10% -$1.67M
TIF
49
DELISTED
Tiffany & Co.
TIF
$15.7M 0.43%
119,476
+102
+0.1% +$11.6K
EFA icon
50
iShares MSCI EAFE ETF
EFA
$78.5B
$15.3M 0.41%
227,717
-30,390
-12% -$2.13M

Similar funds

Oppenheimer & Co's Q2 2018 Portfolio in Review

As of Q2 2018, Oppenheimer & Co held 1,437 positions worth $3.68B, down 5.4% from $3.89B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer & Co withdrew a net $341M in Q2 2018, closing 111 positions and reducing 590 holdings. Its most notable exit was Monsanto Co, an estimated $9.28M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Oppenheimer & Co opened a new position in Thor Industries worth $3.01M.

  • Oppenheimer & Co's largest Q2 2018 buy was Thor Industries: 30,900 shares worth $3.01M.
  • Oppenheimer & Co added most to AT&T in Q2 2018, an estimated $7.02M increase.
  • Oppenheimer & Co's biggest Q2 2018 reduction was Foundation Medicine, Inc., cutting an estimated $63.6M.
  • Oppenheimer & Co fully exited Monsanto Co in Q2 2018, selling an estimated $9.28M.
  • Oppenheimer & Co's ten largest holdings make up 14% of its $3.68B portfolio in Q2 2018.
  • Oppenheimer & Co opened 112 new positions and closed 111 in Q2 2018.
  • Oppenheimer & Co's portfolio value fell 5.4% quarter-over-quarter to $3.68B.

Based on Oppenheimer & Co's 13F filing for Q2 2018, filed 10 Aug 2018.